Related by context. All words. (Click for frequent words.) 68 autoimmune 66 autoimmune diseases 64 myelofibrosis polycythemia vera 62 multiple sclerosis psoriasis 62 autoimmune disorders 62 inflammatory diseases 62 RNAi therapeutic targeting 61 kidney urologic 61 immunomodulators 61 myeloproliferative disorders 61 Psoriatic arthritis 61 inflammatory autoimmune 61 posaconazole 61 demyelinating disease 60 Systemic lupus erythematosus SLE 60 chemotherapy induced neutropenia 60 autoimmune disease 60 systemic lupus erythematosus 60 AT1R 60 immunomodulatory 60 cutaneous lupus 59 neoplastic 59 diabetic nephropathy 59 chronic inflammatory 59 granulomatous 59 SSc 59 FLT3 59 selective inhibition 59 psoriasis rheumatoid arthritis 59 systemic autoimmune 59 IAP inhibitor 59 haematologic 59 underlying vasculopathy 59 myeloproliferative diseases 59 hypereosinophilic syndrome 59 tumor lysis syndrome 59 fibrotic disease 59 immuno inflammatory diseases 59 NF kB pathway 59 cardio renal 59 hematologic malignancies 59 hematologic disorders 58 activin 58 Sezary syndrome 58 CYT# potent vascular disrupting 58 vidofludimus 58 uveitis 58 neurotrophic 58 IL 1ß 58 novel VDA molecule 58 methicillin susceptible Staphylococcus aureus 58 Sudhir Agrawal D.Phil 58 bone marrow suppression 58 Enzastaurin 58 Myelodysplastic syndromes MDS 58 ophthalmic diseases 58 TLR9 agonists 58 lung fibrosis 58 experimental autoimmune encephalomyelitis 58 oral prodrug 58 autoimmune inflammatory 58 NAGS deficiency 58 immuno inflammatory 58 autoimmunity 58 investigational compounds 58 Autoimmune disorders 58 immunological diseases 58 PAOD 58 Epratuzumab 58 immune modulating 58 including thyroiditis RA 58 EGFR HER2 58 C5aR 58 renal fibrosis 58 superantigens 58 Vascular Endothelial Growth 58 immune modulators 58 tauopathies 58 V#F mutation 58 neurodegenerative 58 plasma kallikrein 58 unknown etiology 58 Th2 cytokines 57 immune modulatory 57 vapreotide acetate 57 PXD# 57 SGLT2 57 coronary vasodilation 57 CTGF 57 JAK1 57 angioedema 57 receptor tyrosine kinase inhibitor 57 hematologic diseases 57 HCV protease 57 Xanafide 57 immune dysregulation 57 Neulasta ® 57 demyelination 57 systemic lupus erythematosus psoriasis 57 essential thrombocythemia 57 HuLuc# 57 HDACi 57 immune modulator 57 nephrotoxicity 57 metastatic neuroendocrine tumors 57 anemias 57 dasatinib Sprycel ® 57 allergic inflammation 57 apoptotic pathway 57 Factor VIIa 57 herpes simplex viruses 57 TÎ ² 4 57 mastocytosis 57 anti CD3 57 cytoprotective 57 VEGF receptor 57 systemic lupus erythematosus SLE 57 TLR antagonist 57 erythematosus 57 arterial thrombosis 57 humanized anti 57 imatinib resistant 57 deacetylase inhibitors 57 rheumatoid arthritis gout 57 psoriasis psoriatic arthritis 57 interferons 57 Chronic lymphocytic leukemia 57 inducible nitric oxide synthase 57 CIDP 57 inflammatory autoimmune diseases 57 beta 1a 57 pediatric Crohn disease 57 TGF β 57 sJIA 57 Pulmonary arterial hypertension 57 panitumumab Vectibix 57 immunological 56 Pseudomonas aeruginosa infections 56 TNF antagonist 56 sortilin 56 JAK2 enzyme 56 cytomegalovirus CMV 56 myeloproliferative neoplasms 56 protein tyrosine phosphatase 1B 56 CTLA 4 56 TNF α 56 terlipressin 56 Immunotherapeutic 56 diabetic kidney 56 lupus nephritis 56 hypercalcemia 56 demyelinating 56 TREANDA 56 anterior uveitis 56 inflammatory demyelinating 56 systemic fungal infections 56 arthritis PsA 56 Leber Hereditary Optic Neuropathy 56 receptor inhibitor 56 neurodegenerative diseases 56 pathogenesis 56 Flt3 56 neuropathic pain 56 IL 1beta 56 TACI Ig 56 immunopathology 56 innate immune 56 carcinoid syndrome 56 epithelial tumors 56 Inflammatory bowel diseases 56 viral hemorrhagic fevers 56 Tß4 56 chronic eosinophilic leukemia 56 pheochromocytoma 56 neovascular diseases 56 Th1 cells 56 interleukin IL -# 56 prostaglandin D2 56 sodium glucose cotransporter 56 humanized monoclonal antibody 56 Myelofibrosis 56 investigational humanized monoclonal antibody 56 calcineurin inhibitors 56 Cutaneous T 56 erythropoietic 56 acute coronary syndromes ACS 56 solid tumors 56 proliferative disorders 56 basiliximab 56 neurological manifestations 56 Rituximab 56 hypoxia inducible factor 56 immune modulation 56 neovascularization 56 autoimmune thyroid 56 MAPK pathway 56 ADAMTS# 56 EGFr 56 multiple myeloma MM 56 investigational monoclonal antibody 56 immunomodulator 56 invasive candidiasis 56 biologic pathway 56 reperfusion injury 56 bone metastasis 56 TLR7 56 atacicept 56 diarrhea predominant irritable 56 inflammatory disorders 56 factor TNF 56 gastric carcinogenesis 56 androgen receptor AR 56 kallikrein 56 familial amyloidotic polyneuropathy FAP 56 Enbrel Humira 56 CTAP# Capsules 56 neuropathic pain metabolic diseases 56 Etanercept 56 von Willebrand disease 56 leukemic 56 interferon alpha 56 ALN TTR 56 HDAC inhibition 56 AA Amyloidosis 56 adenoviral 56 cirrhosis liver failure 56 diabetic peripheral neuropathy 56 peptide antigens 56 JAK inhibitors 55 Valortim R 55 orally administered inhibitor 55 proteoglycan 55 erlotinib Tarceva ® 55 inflammatory bowel diseases 55 seropositive patients 55 remyelination 55 skeletal muscle weakness 55 CD# antibody [001] 55 neutropenia thrombocytopenia 55 anti fibrotic 55 neuropsychiatric diseases 55 myeloproliferative 55 Kepivance 55 actinic keratosis 55 targeting CD# 55 Tβ4 55 telomere dysfunction 55 LHRH antagonists 55 fibrotic 55 Glucocorticoids 55 neovascular 55 thromboembolic disease 55 pro inflammatory cytokines 55 serotonergic 55 interleukins 55 Factor VEGF 55 Dacogen injection 55 non alcoholic steatohepatitis 55 superficial basal cell carcinoma 55 immunostimulatory 55 Multiple sclerosis MS 55 lymphoma subtypes 55 mGluR2 NAM 55 dermatological disorders 55 HuMax CD4 55 induce apoptosis 55 FGFR 55 bendamustine 55 antibody mediated 55 HeFH 55 cell lymphomas 55 B lymphocyte stimulator 55 sodium thiosulfate STS 55 rheumatoid arthritis multiple sclerosis 55 Friedreich Ataxia FRDA 55 juvenile idiopathic arthritis 55 neutrophil recruitment 55 BCG refractory 55 IL 1β 55 Hereditary angioedema HAE 55 TTR gene 55 neuroendocrine 55 idiopathic thrombocytopenic purpura ITP 55 A1PI 55 epithelial cancers 55 vascular permeability 55 mTOR mammalian target 55 PDE4 55 basophils 55 Seliciclib 55 heparin induced thrombocytopenia 55 carcinoid 55 metastatic malignant 55 chronic autoimmune 55 transthyretin TTR mediated amyloidosis 55 ANCA associated 55 LPA1 receptor 55 Gleevec resistant 55 cytokines IL 55 rheumatoid arthritis juvenile idiopathic 55 Angiotensin II 55 haematopoietic 55 INS# [001] 55 ENMD # 55 MGd 55 Natalizumab 55 humanized monoclonal 55 rheumatoid arthritis RA psoriatic 55 cardiometabolic disorders 55 delta gamma agonist 55 CD#b 55 alpha interferons 55 γ secretase 55 E#F# 55 immunologic diseases 55 YONDELIS R 55 Atopic dermatitis 55 chronic HCV infection 55 secondary hyperparathyroidism 55 cytokine 55 potent antiproliferative 55 c MET 55 small molecule inhibitors 55 chronic HBV infection 55 IGF 1R 55 Interferon beta 55 TLR antagonists 55 ADP receptor antagonist 55 VAPRISOL 55 preclinical models 55 pan HDAC inhibitor 55 ocular inflammatory 55 Aurora kinase 55 IFN gamma 55 mediated inflammatory 55 thrombopoietin 55 hypothalamic pituitary adrenal axis 55 cardiovascular disorders 55 demyelinating diseases 55 CD# monoclonal antibody 55 TELINTRA 55 Ribavirin causes 55 thalidomide Thalomid 55 polyneuropathy HIV DSP 55 Squalamine 55 protein tyrosine phosphatases 55 anticancer treatments 55 IGFBP 3 55 pancytopenia 55 ankylosing spondylitis AS 55 proapoptotic 55 systemic inflammation 55 serotonin receptor 55 Personalized Immunotherapy 55 immuno modulatory 55 capillary leak 55 drugable targets 55 immunologic 55 anticancer therapy 55 neoplastic diseases 55 immunomodulation 55 eNOS 55 YONDELIS 55 neuronal dysfunction 55 lenalidomide dexamethasone 55 JAK2 inhibitor 55 Neuropathic pain 55 CCR9 antagonist 55 proteasome inhibitor 55 hematologic 55 small molecule activators 55 TNFalpha 55 CYT# 55 fibrosis 55 leukocyte adhesion 55 immunomodulatory effects 55 Smad3 55 interferon γ 55 Angiotensin converting enzyme 55 vascular disrupting agents 55 antisense inhibitor 55 neuroinflammation 55 AAT Deficiency 54 catheter occlusion 54 histone deacetylase HDAC 54 papillary renal cell carcinoma 54 allograft rejection 54 PDE# inhibitors 54 rheumatoid arthritis Crohn disease 54 acute GvHD 54 Navelbine 54 multi kinase inhibitor 54 bortezomib Velcade 54 vWD 54 IFN γ 54 anakinra 54 small molecule thrombopoietin 54 erythropoiesis 54 uric acid lowering 54 thetreatment 54 debilitating autoimmune 54 nosocomial pneumonia 54 FOXP3 54 glomerulonephritis 54 Aviptadil 54 lupus multiple sclerosis 54 pleiotropic 54 effector function 54 MTP inhibitor 54 Homspera 54 basal cell carcinoma BCC 54 beta interferons 54 Ceflatonin 54 coagulation cascade 54 Hematologic 54 A3 adenosine receptor 54 Xyfid TM 54 Fludara ® 54 tumor metastasis 54 humoral immunity 54 GSK # 54 MMP inhibitors 54 imatinib Gleevec ® 54 PDGFR 54 fungal bacterial 54 severe hypersensitivity reactions 54 vaginal candidiasis 54 dermatological diseases 54 daptomycin 54 polycythemia vera PV 54 cAMP signaling 54 TYZEKA 54 TLR9 agonist 54 5 HT6 receptor 54 rheumatic disease 54 Neutropenia 54 TTR amyloidosis 54 leukemia AML 54 mycophenolate mofetil 54 bevacizumab Avastin ® 54 Vaprisol 54 pharmacodynamic biomarkers 54 cell adhesion molecule 54 bexarotene 54 constipation OIC 54 rFVIIa 54 antibody MAb 54 endogenous ligands 54 CCR9 54 p# inhibitor 54 Traficet EN 54 lymphoid organs 54 JAK3 54 coagulation disorders 54 immunosuppressive therapies 54 #ME# 54 esophageal candidiasis 54 antitumoral 54 somatostatin 54 cardiovascular cerebrovascular 54 airway hyperresponsiveness 54 selective modulator 54 Fc fusion protein 54 ischemic diseases 54 lymphoid malignancies 54 azacytidine 54 antiangiogenic 54 Virulizin ® 54 mTOR inhibitors 54 serine protease 54 antiinflammatory 54 lysosomal storage diseases 54 pathogenic mechanisms 54 cilengitide 54 NTDDS 54 progressive neurodegenerative disorder 54 antitumor 54 microtubule targeting 54 NFkB 54 MELAS 54 T1DM 54 induced macular edema 54 Vidaza azacitidine 54 hyperparathyroidism 54 acetonide FA 54 somatostatin analogues 54 acne rosacea 54 TNFα 54 rheumatic diseases 54 myelofibrosis 54 dextromethorphan quinidine 54 GvHD 54 Azilect ® 54 vWF 54 endotoxemia 54 S1P 54 multiple sclerosis rheumatoid arthritis 54 cIAI 54 immune thrombocytopenic purpura 54 EGFR inhibitors 54 response syndrome SIRS 54 varicella zoster virus 54 lupus scleroderma 54 nonsense mutation 54 riociguat 54 Cytotoxic T 54 Autoimmune diseases 54 Systemic lupus erythematosus 54 immune responses 54 rheumatologic 54 potent cytotoxic 54 cell malignancies 54 cytopenias 54 immunosuppressive 54 sPLA2 54 tumor xenograft models 54 Chronic Inflammatory Demyelinating Polyneuropathy 54 essential thrombocythemia ET 54 hematological malignancies 54 paclitaxel Taxol 54 postoperative ileus POI 54 Bronchiectasis 54 BCR ABL 54 biologic therapy 54 mycosis fungoides 54 neurodegenerative disorders 54 metastatic bone 54 xenograft models 54 Cushing syndrome 54 LPS induced 54 Cimzia ® certolizumab pegol 54 prostaglandin synthesis 54 varicella zoster virus VZV 54 post herpetic neuralgia PHN 54 histone deacetylase HDAC inhibitor 54 iNOS 54 GM CSF 54 imatinib Gleevec 54 resolvins 54 TNF inhibitors 54 EGF receptor 54 IL #E 54 oral JAK1 54 alefacept 54 neuroinflammatory 54 FTIs 54 cytomegalovirus infection 54 azoles 54 alkylating agent 54 Acute Bacterial Sinusitis ABS 54 decitabine 54 Evoltra ® 54 delay bone metastases 54 elotuzumab 54 interferon IFN 54 p# MAPK 54 Escherichia coli Klebsiella pneumoniae 54 bone metastases 54 neurite outgrowth 54 CTLA4 Ig 54 PNP inhibitor 54 oropharyngeal candidiasis 54 Erythropoietic therapies may 54 sunitinib Sutent ® 54 trabectedin 54 Rebif ® 54 systemic juvenile idiopathic 54 IGF IR 54 synthetic retinoid 54 lactic acidosis 54 Ocrelizumab 54 rheumatoid arthritis osteoarthritis ankylosing 54 peptibody 54 GABITRIL 54 cellular pathways 54 investigational therapies 54 Daclizumab 54 receptor subtype 54 L asparaginase 54 gastrointestinal disorders characterized 54 thrombocytopenia 54 CD#L 54 recurrent glioblastoma multiforme 54 PLX cells 54 Omacetaxine 54 TB4 54 ocular infections 54 hepatocellular carcinoma 54 Symadex 54 tumorigenesis 54 proliferative diseases 54 epiglottitis 54 Severe Primary IGFD 54 cannabinor 54 nalbuphine ER 54 cetuximab Erbitux ® 54 Idiopathic pulmonary fibrosis IPF 54 5 HT2A receptor 54 PAR1 54 cSSSIs 54 signaling cascades 54 pDCs 54 cMET 54 pemphigoid 54 antibody therapies 54 post herpetic neuralgia 54 formerly LymphoStat B 54 Hedgehog signaling 54 included exfoliative dermatitis 54 VEGF inhibitors 54 elastase 54 bacterial fungal 54 hypoparathyroidism 54 cytokine signaling 54 osteogenic 54 cardiovascular ischemic 54 VEGF 54 GGF2 53 Plaque psoriasis 53 LRP5 53 c myc 53 induces apoptosis 53 NSAID induced 53 engineered RAP peptides 53 Dysregulation 53 recurrent genital herpes 53 JAK inhibitor 53 idiopathic pulmonary fibrosis IPF 53 Pemetrexed 53 ACTEMRA 53 Degarelix 53 G#DT 53 myositis 53 acadesine 53 Fibromyalgia Syndrome FMS 53 oral antiviral 53 TMEM#B 53 mu opioid receptor antagonist 53 benign prostatic hypertrophy BPH 53 histone deacetylase 53 Tumor Necrosis Factor 53 lupus erythematosus 53 ocular diseases 53 ophthalmic indications 53 P#X# 53 mitochondrial dysfunction 53 hyperammonemia 53 cutaneous squamous cell carcinoma 53 Rheumatoid arthritis RA 53 Sjögren syndrome 53 synovial cells 53 TNFa 53 C5a 53 Wnt signaling pathway 53 ischemic complications 53 myeloma cells 53 neuro inflammatory 53 hepatitis C virus HCV 53 Solazed TM 53 hepatitis C HCV 53 Toxicities 53 liposomal formulation 53 rheumatoid arthritis psoriatic arthritis 53 infectious diseases autoimmune diseases 53 JAK2 inhibitors 53 adalimumab Humira 53 osteopontin 53 IL #R 53 TSLP 53 Enkephalin 53 hedgehog pathway 53 innate immune responses 53 cytotoxic T lymphocyte 53 sarcomas 53 airway remodeling 53 cardiovascular metabolic 53 posterior uveitis 53 GW# [003] 53 molecularly targeted 53 calcineurin inhibitor 53 small molecule defensin 53 idiopathic thrombocytopenic purpura 53 phosphatases 53 candidiasis 53 atypical hemolytic uremic syndrome 53 Carcinoid tumors 53 Aflibercept 53 Tumor necrosis factor 53 TLR8 53 DAS# [001] 53 IgG1 monoclonal antibody 53 peripherally acting 53 enzastaurin 53 PRT# 53 IFN alpha 53 neuroendocrine tumors 53 antitumor efficacy 53 hematological cancers 53 drug ISA# 53 uPA 53 receptor inhibitors 53 inflammatory mediators 53 Clusterin 53 Delta opioid receptor 53 intestinal epithelium 53 pathogenetic 53 epilepsy Parkinson disease 53 pegylated 53 Bortezomib 53 angiogenic responses 53 simplex virus 53 efalizumab 53 immunotherapeutic 53 biologic therapeutics 53 MEK inhibitors 53 microvascular complications 53 small molecule agonists 53 antimetabolite 53 tumor metastases 53 GRNCM1 53 neurological diseases 53 chronic myelogenous leukemia CML 53 IgG1 antibody 53 purpura ITP 53 mGlu2 3 53 ON #.Na 53 RANK ligand 53 Candida infection 53 RGB # 53 postherpetic neuralgia PHN 53 disease modifying 53 fluoroquinolone antibiotic 53 beta defensins 53 ABCB1 53 MyVax R 53 Cyclosporine 53 rheumatoid arthritis systemic lupus 53 visilizumab 53 Epstein Barr Virus EBV 53 vinca alkaloid 53 interstitial pneumonia 53 receptor subtypes 53 R Saizen R 53 diabetic gastroparesis 53 aHUS 53 MYCAMINE 53 Hedgehog pathway 53 Treg cell 53 antithrombotic 53 Golimumab 53 ara C 53 ankylosing spondylitis 53 cytolytic 53 muscular dystrophies 53 anti angiogenic 53 Leukotrienes 53 Acute Radiation Syndrome ARS 53 STELARA TM 53 clinically heterogeneous 53 nilotinib Tasigna ® 53 arthritis RA 53 IRX 2 53 osteoclast 53 adipogenic 53 G6PD deficiency 53 Fas ligand 53 MALT lymphoma 53 adenosine A2A 53 mesenchymal cell 53 hormone gastrin 53 inverse agonist 53 autosomal recessive disorder 53 ALN TTR# 53 TLR9 53 pro angiogenic 53 Smac mimetics 53 lectin pathway 53 bacterial parasitic 53 B CLL 53 ATTR PN 53 ACh 53 receptor agonist 53 novel peptide 53 HSP# inhibitor 53 tiapamil 53 cachexia 53 relapsing forms 53 PsA 53 clusterin 53 OXi# 53 sunitinib Sutent 53 dyslipidemia 53 Omacetaxine mepesuccinate 53 VEGF inhibition 53 subependymal giant cell 53 Cushing Syndrome 53 PTP 1B 53 GGTase 53 ocular disorders 53 1 diabetes T1D 53 LHRH receptor positive 53 PDE#A 53 refractory gout 53 gastrointestinal stromal tumors GISTs 53 bleomycin 53 recombinant erythropoietin 53 5 HT6 53 Hsp# inhibitors 53 humanized antibody 53 leukemia CLL 53 vaso occlusive crisis 53 Icatibant 53 gastric carcinoma 53 T2DM 53 molecular biomarkers 53 metastatic colorectal 53 TORISEL 53 muscarinic 53 neuroprotection 53 ACZ# 53 Systemic lupus 53 mucosal 53 anticancer agent 53 glucocorticoids 53 Anti VEGF 53 Romiplostim 53 downregulation 53 Idiopathic pulmonary fibrosis 53 potent anti angiogenic 53 organ transplant rejection 53 oncogenesis 53 velafermin 53 panobinostat 53 post herpetic 53 IMiDs ® compound 53 neoplasm 53 AEG# 53 IFN ß 53 NS5A 53 histone deacetylase inhibitor 53 Lymphomas 53 metastatic RCC 53 MyVax ® 53 proinflammatory 53 acute leukemias 53 Vidofludimus 53 adhesion molecule 53 erythema nodosum 53 pemphigus 53 proinflammatory cytokines 53 preclinically 53 osteoarthritis rheumatoid arthritis 53 TMS Therapy 53 olmesartan 53 Hashimoto thyroiditis 53 noninfectious uveitis 53 Eculizumab 53 imatinib resistance 53 chemokine receptor 53 ERK signaling 53 myocardial infarction ventricular fibrillation 53 Interferon gamma 53 Prion diseases 53 CEQ# 53 tryptase 53 etanercept Enbrel 53 hyperinsulinemia 53 LymphoStat B belimumab 53 ocrelizumab 53 steroid refractory ulcerative 53 T#I [002] 53 Crohn disease CD 53 alemtuzumab MS 53 evaluating tivozanib 53 cell lymphoma CTCL 53 mitochondrial toxicity 53 angiogenesis inhibitor 53 rheumatoid arthritis 53 transplantation HCT 53 DAVANAT 53 alpha TNF 53 Morquio 53 respiratory gastrointestinal 53 Th# 53 lymphoid 53 neurofibromin 53 pertuzumab 53 Janus kinase 53 APOPTONE 53 neovascular age 53 lymphomas 53 immune suppression 53 CsA 53 cancer cachexia 53 DOS# 53 TGFβ 53 Synavive 53 vascular inflammation 53 Cx# [002] 53 mediated apoptosis 53 cytotoxic T 53 receptor antagonists 53 Factor Receptor 53 antitumor immune 53 herpes zoster 53 malignant lymphomas 53 severe malignant osteopetrosis 53 #HT#A 53 Remicade infliximab 53 proliferative diabetic retinopathy 53 glucagon receptor 53 PI3 kinase 53 proliferator activated receptor 53 abnormal angiogenesis 53 hematopoietic 53 Prostaglandins 53 antibody fragment 53 kinase inhibitor 53 Hemophilia B 53 melanocortin 53 incretin 53 antifibrotic 53 AA amyloidosis 53 Systemic Lupus Erythematosus SLE 53 HBeAg negative 53 bone morphogenetic proteins 53 anti secretory 53 Tasimelteon 53 small molecule tyrosine 53 T lymphocyte 53 VIPR2 53 COX2 53 PRTX 53 diabetic macular edema 53 allogeneic stem cell 53 Proxinium TM 53 polyarticular 53 β cells 53 CCR2 53 MMP2 53 pathophysiological effects 53 Akt activation 53 Epidermal Growth Factor Receptor 53 VEGF protein 53 monoclonal antibody 53 colon carcinoma 53 2 inhibitor CYT# 53 alveolar epithelial cells 53 Cytomegalovirus CMV 53 chronic autoimmune disorder 53 Vfend 53 calcineurin 53 cutaneous T cell 53 insulin sensitizer 53 oral JAK#/JAK# inhibitor 53 peptidic compound 53 TNF alpha 53 relapsed multiple myeloma 53 R sorafenib tablets 52 neurogenic orthostatic hypotension 52 cystic fibrosis chronic pancreatitis 52 Th2 52 PDGF receptor 52 renin angiotensin aldosterone 52 N methyl 52 rheumatoid arthritis psoriasis 52 cytotoxic 52 Kit CD# positive 52 VZV 52 relapsing remitting multiple sclerosis 52 Neurodegenerative diseases 52 pemphigus vulgaris 52 SYN# 52 Diabetic Macular Edema 52 oncogenic 52 Ranibizumab 52 candidemia 52 cholecystokinin CCK 52 NF1 52 protein kinase inhibitors 52 prokinetic agent 52 commercializes innovative biopharmaceuticals 52 malignant neoplasms 52 tyrosine kinase inhibitor 52 RANK Ligand 52 Hedgehog Pathway Inhibitor 52 microglial activation 52 relapsed leukemia 52 mitogenic 52 zileuton 52 ESBA# 52 mitogen activated protein kinase 52 tyrosine kinase inhibitors TKIs 52 BRAF inhibitor 52 pathophysiological 52 TRAIL induced apoptosis 52 mGluR5 NAM 52 premalignant 52 VEGF receptors